| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 74.77B | 73.25B | 63.12B | 65.08B | 62.67B | 59.14B |
| Gross Profit | 19.24B | 18.24B | 13.15B | 12.96B | 15.72B | 15.18B |
| EBITDA | 9.10B | 8.68B | 5.85B | 3.83B | 7.98B | 7.46B |
| Net Income | 2.96B | 2.58B | 1.17B | -407.00M | 2.49B | 2.56B |
Balance Sheet | ||||||
| Total Assets | 94.19B | 97.11B | 94.54B | 85.03B | 86.47B | 85.03B |
| Cash, Cash Equivalents and Short-Term Investments | 15.44B | 16.75B | 16.13B | 9.13B | 12.22B | 11.60B |
| Total Debt | 29.98B | 31.35B | 35.14B | 32.47B | 30.87B | 32.10B |
| Total Liabilities | 50.29B | 52.60B | 53.24B | 46.73B | 46.08B | 47.63B |
| Stockholders Equity | 38.95B | 38.73B | 36.75B | 34.35B | 36.77B | 34.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.39B | 4.59B | -2.11B | 2.86B | 557.00M |
| Operating Cash Flow | 0.00 | 7.53B | 7.09B | 724.00M | 5.52B | 4.96B |
| Investing Cash Flow | 0.00 | -2.14B | -2.01B | -2.88B | -2.70B | -3.80B |
| Financing Cash Flow | 0.00 | -5.04B | 1.65B | -1.03B | -2.34B | 255.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥115.15B | 12.08 | 9.19% | 3.33% | -17.97% | ― | |
74 Outperform | ¥145.44B | 18.74 | ― | 0.93% | 10.27% | -5.66% | |
73 Outperform | ¥120.13B | 25.17 | 5.56% | 2.59% | 2.58% | -3.16% | |
73 Outperform | ¥123.10B | 26.50 | ― | 3.77% | 9.07% | 152.79% | |
63 Neutral | ¥91.53B | 10.65 | ― | 1.24% | 8.78% | 19.37% | |
62 Neutral | ¥95.87B | 19.44 | ― | 1.30% | 47.56% | 49.58% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |